Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma With Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in ...
In a recent review published in BMC Medicine, scientists evaluate artificial intelligence models (AI-Ms) that predict cardiovascular disease (CVD) risks in general and specific populations while also ...
Computational models and simulations have had an important role in engineering analysis since as far back as the 1960s. It is widely recognized that the use of modeling and simulation tools can make ...
Dr. Siva Samy is the founder and CEO of ValGenesis, an inventor with 8 patents in digital and AI-based validation, and a Ph.D in Pharma. For decades, validation in life sciences has been treated as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results